Juvenile spondyloarthritis is a group of inflammatory diseases affecting children and teenagers, causing pain and swelling in the joints, spine, and places where tendons attach to bone. Understanding the treatment options available—from medications that reduce inflammation to physical therapy and new therapies being tested in clinical trials—can help families manage symptoms, preserve mobility, and improve quality of life for young people living with this condition.

Understanding Treatment Goals for Young People with Spondyloarthritis

When a child or teenager is diagnosed with juvenile spondyloarthritis, the main focus of treatment is to control symptoms, reduce inflammation, and preserve joint function as the young person continues to grow. The goal is to help children lead as normal a life as possible, participating in school, sports, and activities with their peers, while preventing long-term damage to their joints and spine. Because symptoms can vary greatly from one child to another, treatment plans are always tailored to the individual, taking into account the severity of disease, which joints are affected, and how the condition impacts daily life.^[1][11]

Treatment decisions also depend on how well a child responds to initial therapies and whether certain features suggest a more aggressive disease course. For example, inflammation of the hip joint or the spine, or having the genetic marker called HLA-B27 (a protein found on immune cells that increases risk), may signal the need for more intensive treatment approaches. Medical teams work closely with families to adjust therapy over time, balancing effectiveness with potential side effects to ensure the best possible outcome.^[2][9]

Standard treatments approved by medical societies form the foundation of care, but many researchers are also investigating new therapies in clinical trials. These studies explore innovative approaches to controlling inflammation and preventing joint damage, offering hope that future treatments will be even more effective and easier for young patients to tolerate.^[3]

Standard Treatment Approaches

The first line of treatment for juvenile spondyloarthritis typically involves nonsteroidal anti-inflammatory drugs, often abbreviated as NSAIDs. These medications help reduce pain and inflammation in the joints and are often the starting point for children with mild to moderate symptoms. Common NSAIDs include ibuprofen and naproxen, which work by blocking chemicals in the body that cause inflammation. Because they are relatively safe and well-tolerated in most children, doctors often begin with these medications to see if symptoms can be controlled without needing stronger drugs. However, NSAIDs must be used carefully over long periods, as they can sometimes cause stomach upset or, rarely, affect kidney function.^[11][10]

When NSAIDs alone are not enough to control disease activity, or when there are signs of more serious joint involvement, doctors may add disease-modifying antirheumatic drugs, or DMARDs. The most commonly used DMARD in children with juvenile spondyloarthritis is sulfasalazine. This medication helps to slow down the disease process and reduce inflammation, particularly in peripheral joints like the knees and ankles. However, sulfasalazine is generally less effective for inflammation of the spine itself. Children taking this medication require regular blood tests to monitor for potential side effects, such as changes in blood cell counts or liver function.^[9][11]

For children who do not respond well to NSAIDs and traditional DMARDs, or who have severe disease affecting the spine or hips, doctors often turn to a newer class of medications called biologic therapies. The most widely used biologics for juvenile spondyloarthritis are tumor necrosis factor inhibitors, or TNF inhibitors. These drugs work by blocking a specific protein in the body called tumor necrosis factor, which plays a major role in causing inflammation. Examples of TNF inhibitors approved for use in children include etanercept, adalimumab, and infliximab. These medications have transformed the treatment of juvenile spondyloarthritis, as they can dramatically reduce pain and stiffness, prevent joint damage, and improve overall quality of life.^[11][9]

In some cases, when children experience severe flares of inflammation, doctors may prescribe corticosteroids for short-term use. These powerful anti-inflammatory drugs can quickly reduce swelling and pain, but they are not intended for long-term use in children because of potential side effects such as weight gain, bone thinning, and growth suppression. Corticosteroids may be given as pills, or they can be injected directly into an inflamed joint to provide targeted relief without affecting the whole body.^[10]

Medications are only part of the treatment picture. Physical therapy plays a crucial role in maintaining joint flexibility, strengthening muscles around affected areas, and preventing stiffness. A physical therapist will design exercises specifically for each child, focusing on stretching the spine, strengthening core muscles, and maintaining good posture. Regular physical activity, including swimming, stretching exercises like yoga or tai chi, and gentle cardio, is strongly encouraged. Exercise helps reduce pain, prevents joints from becoming stiff, and supports overall physical and emotional health.^[11][14]

Treatment duration varies widely depending on how well a child responds to therapy. Some children may need to stay on medications for several years, while others may be able to reduce or stop treatment if their disease goes into remission. Unfortunately, achieving complete remission is less common in juvenile spondyloarthritis than in some other forms of childhood arthritis. Studies have shown that fewer than 20 percent of children with this condition achieve remission within five years of diagnosis, which underscores the importance of ongoing monitoring and adjustments to treatment plans.^[5]

Innovative Therapies Being Tested in Clinical Trials

While standard treatments have improved outcomes for many children with juvenile spondyloarthritis, researchers continue to search for new and better therapies. Clinical trials are research studies that test new medications or treatment approaches to see if they are safe and effective. These trials are conducted in phases, each with a specific purpose. Phase I trials focus on safety and determine the correct dose of a new drug. Phase II trials examine whether the treatment actually works to reduce disease activity or improve symptoms. Phase III trials compare the new treatment with existing standard therapies to see if it offers additional benefits.^[3]

One area of active research is the development of new biologic drugs that target different parts of the inflammatory process. For example, some clinical trials are testing medications that block other inflammatory proteins beyond tumor necrosis factor. These include drugs that target interleukin-17 (IL-17) and interleukin-23 (IL-23), which are molecules known to play important roles in driving inflammation in spondyloarthritis. By blocking these molecules, researchers hope to control inflammation in patients who do not respond well to TNF inhibitors or who experience side effects from them.^[9]

Another promising approach being explored is the use of Janus kinase inhibitors, or JAK inhibitors. These are small molecule drugs that work inside immune cells to block signals that lead to inflammation. Unlike biologics, which are given by injection or infusion, JAK inhibitors are taken as pills, which can be more convenient for children and families. Some JAK inhibitors have already been approved for use in adults with spondyloarthritis, and studies are underway to determine their safety and effectiveness in children and adolescents.^[3]

Clinical trials for juvenile spondyloarthritis are conducted at major medical centers around the world, including in the United States, Europe, and other regions. Eligibility for these trials depends on factors such as the child’s age, how long they have had the disease, which treatments they have already tried, and the severity of their symptoms. Families interested in learning about clinical trials can speak with their child’s rheumatologist, who can provide information about available studies and whether their child might be a good candidate. Participating in a clinical trial can give children access to cutting-edge therapies before they become widely available, and it also contributes to scientific knowledge that may benefit other young patients in the future.^[3]

While specific trial results and code names of experimental drugs were not detailed in the source materials, the overarching message from the research community is clear: there is ongoing, intensive work to develop better treatments for juvenile spondyloarthritis. These efforts focus on finding medications that are more effective, easier to take, and have fewer side effects, with the ultimate goal of helping children achieve remission and maintain normal growth and development.^[3]

Most common treatment methods

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • First-line medications that reduce pain and inflammation in joints
  • Examples include ibuprofen and naproxen
  • Generally well-tolerated but require monitoring for potential stomach or kidney effects
• Disease-Modifying Antirheumatic Drugs (DMARDs)
  • Sulfasalazine is the most common DMARD used for juvenile spondyloarthritis
  • Helps slow disease progression and reduce inflammation in peripheral joints
  • Requires regular blood tests to monitor for side effects
• Biologic Therapies
  • Tumor necrosis factor (TNF) inhibitors such as etanercept, adalimumab, and infliximab
  • Block specific proteins that cause inflammation
  • Given by injection or infusion
  • Dramatically reduce symptoms and prevent joint damage
  • Require monitoring for increased infection risk
• Corticosteroids
  • Used for short-term relief during severe flares
  • Can be given as pills or injected directly into inflamed joints
  • Not recommended for long-term use due to potential side effects on growth and bone health
• Physical Therapy and Exercise
  • Essential for maintaining flexibility, strength, and posture
  • Includes stretching, core strengthening, and cardiovascular activities
  • Swimming, yoga, and tai chi are particularly beneficial
  • Reduces pain and prevents joint stiffness

Supporting Overall Health and Well-being

Beyond medications and physical therapy, lifestyle factors play an important role in managing juvenile spondyloarthritis. Maintaining good posture throughout the day can help prevent stiffness and deformities of the spine. Parents and caregivers can encourage children to practice standing tall and sitting up straight, and physical therapists often teach specific posture exercises. Sleeping on a firm mattress and using a thin pillow or no pillow can also support spinal alignment during rest.^[11][14]

Diet and nutrition are also important considerations. While there is no specific diet proven to cure or treat juvenile spondyloarthritis, eating a balanced diet rich in fresh vegetables, fruits, and whole grains can support overall health and may help reduce inflammation. Some families find it helpful to work with a dietitian who specializes in inflammatory diseases to develop a nutritional plan that meets their child’s needs.^[11][14]

Managing stress and ensuring adequate sleep are equally important. Chronic pain and the challenges of living with a long-term condition can be emotionally difficult for children and teenagers. Stress can also worsen pain and fatigue. Families should look for healthy ways to manage stress, such as relaxation techniques, spending time with pets, engaging in hobbies, or talking with a counselor or therapist. Good sleep hygiene, including a consistent bedtime routine and avoiding screens before bed, can help children get the rest they need to feel their best.^[14][15]

Smoking is particularly harmful for people with spondyloarthritis, as it can worsen symptoms, speed up joint damage, and make treatments less effective. While this is more relevant for older teenagers and parents, creating a smoke-free environment is beneficial for the whole family.^[14]

Working Together as a Team

Treating juvenile spondyloarthritis requires a team approach. The core of the team is usually a pediatric rheumatologist, a doctor who specializes in treating arthritis and related conditions in children. Other important team members may include physical therapists, occupational therapists, nurses, social workers, and sometimes psychologists or counselors. Parents and caregivers are also crucial members of the team, as they help their child follow treatment plans, attend appointments, and advocate for their needs at school and in other settings.^[1][15]

Open communication between all team members is essential. Parents should feel comfortable asking questions, sharing concerns, and discussing how treatment is affecting their child’s daily life. Keeping a notebook to track symptoms, medication doses, side effects, and questions for the doctor can help families stay organized and ensure nothing important is overlooked. This record can also be helpful when meeting with teachers or school staff to arrange accommodations that support the child’s participation in school activities.^[15]

Many families find support from connecting with others who are going through similar experiences. Support groups, either in person or online, provide a space for parents and children to share stories, exchange tips, and feel less alone. Organizations dedicated to spondyloarthritis offer resources, educational materials, and connections to support networks that can be invaluable for families navigating this journey.^[1][15]